Prostate Cancer
Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer.
December 27, 2023
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
December 27, 2023
The Impact of Nutrient Supply on Prostate Cancer Risk Worldwide.
December 27, 2023
Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy.
December 27, 2023
Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management.
December 26, 2023
What are the Most Important Objectives of Patients Undergoing Radical Prostatectomy? A Narrative Review.
December 26, 2023
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer.
December 26, 2023
Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.
December 26, 2023
ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.
December 26, 2023
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer.
December 26, 2023
First clinical and oncological experiences with triplet therapy for high-volume metastatic hormone-sensitive prostate cancer.
December 25, 2023
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer.
December 25, 2023
Blood-based liquid biopsy in advanced prostate cancer.
December 25, 2023